Skip to main content

Heart failure

Latest articles

17-12-2021 | Diabetes | News | Article

Metformin, but not sulfonylurea, may reduce poor outcome risk post HHF

Initiating metformin following hospitalization for heart failure may reduce the risk for death or further HHF in older people with comorbid diabetes, but only if they have a preserved ejection fraction, study findings indicate.

29-08-2021 | Diabetes | News | Article

Empagliflozin has broad beneficial effect on HFpEF outcomes

Empagliflozin treatment produces significant reductions in the risk for a broad range of inpatient and outpatient heart failure outcomes in people with a preserved ejection fraction, shows further analysis of EMPEROR-Preserved.

01-09-2020 | Diabetes | News | Article

EMPEROR-Reduced boosts case for SGLT2 inhibition in HF irrespective of diabetes

The EMPEROR-Reduced investigators have revealed that empagliflozin provides significant protection against cardiovascular death and heart failure in patients with heart failure and reduced ejection fraction, with or without diabetes.

16-06-2020 | Diabetes | News | Article

VERTIS-CV: Similar MACE risk with ertugliflozin vs placebo in type 2 diabetes

Patients with type 2 diabetes and established atherosclerotic disease who are treated with the SGLT2 inhibitor ertugliflozin have a similar risk for major adverse cardiovascular events to those given placebo, shows the VERTIS-CV trial.

01-04-2020 | Diabetes | News | Article

Transplant study shows toxic effects of diabetes on the heart

Follow-up of patients after heart transplant reveals rapid cardiomyocyte lipid accumulation, a probable forerunner of diabetic cardiomyopathy, in those with pre-existing type 2 diabetes.

18-07-2019 | Diabetes | News | Article

Diabetes-associated heart failure risk greatest in women

Diabetes is a stronger risk factor for heart failure among women compared with men, indicate the results of a large systematic review and meta-analysis.

15-02-2017 | Heart failure | News | Article

Elevated hs-cTnT levels could indicate subclinical cardiac disease

Minor increases in high-sensitivity cardiac troponin T levels may represent an early biochemical signature of subclinical heart disease, researchers report.

09-01-2017 | Heart failure | News | Article

Diabetes associated with adverse outcomes in patients with HFpEF

Diabetes is associated with poor prognosis among patients with heart failure and preserved ejection fraction, study results suggest.

05-10-2016 | Heart failure | News | Article

Age key to transcatheter versus surgical aortic valve replacement choice

Researchers report that patients with severe aortic stenosis who have a shorter life expectancy or place a low value on the risk of long-term valve degeneration may have more to gain from transfemoral transcatheter aortic valve implantation than surgical replacement.

29-09-2016 | Heart failure | News | Article

NSAIDs association with heart failure risk quantified

The increased risk of heart failure associated with non-steroidal anti-inflammatory drugs varies between drugs and according to dose, study findings show.

31-08-2016 | Cardiology | News | Article

ICDs fail to reduce long-term mortality in non-ischaemic HF

Prophylactic implantable cardioverter–defibrillator use does not reduce long-term mortality in patients with symptomatic heart failure not caused by coronary artery disease, Danish research shows.

30-08-2016 | Cardiology | News | Article

Sacubitril–valsartan costs may be justified in NYHA class II-IV heart failure

Sacubitril–valsartan is cost-effective for the reduction of cardiovascular mortality and morbidity in patients with New York Heart Association class II to IV heart failure and reduced ejection fraction, US study findings indicate.

24-08-2016 | Heart failure | News | Article

Imaging technique accurately diagnoses ATTR cardiac amyloidosis

Technetium 99m pyrophosphate planar cardiac imaging accurately differentiates transthyretin cardiac amyloidosis from other amyloid conditions and may also predict survival, US researchers report.

12-08-2016 | Cardiology | News | Article

Racial and gender disparities common in ICD counselling

Less than a quarter of heart failure (HF) patients eligible for implantable cardioverter-defibrillator counselling actually receive it, with the rates even lower in women and ethnic minority patients, an observational analysis of the Get With The Guidelines-HF Program shows.

02-08-2016 | Heart failure | News | Article

Advanced heart failure clinical stability not improved by liraglutide

The glucagon-like peptide 1 agonist liraglutide does not improve clinical stability in patients recently hospitalised with advanced heart failure and reduced left ventricular ejection fraction, US researchers report.

01-08-2016 | Heart failure | News | Article

Obesity underlies many current-era high-output HF cases

The causes of high-output heart failure have changed over time, say Mayo Clinic researchers.

29-07-2016 | Heart failure | News | Article

HF patients rarely tested for CAD

Tests for ischaemic coronary artery disease are badly underutilised in patients with new-onset heart failure, research shows.

19-07-2016 | Heart failure | News | Article

Outcomes may be good after ejection fraction recovery

Recovery from a reduced ejection fraction appears to be a predictor of good outcomes in patients with heart failure, a retrospective analysis shows.

18-07-2016 | Heart failure | News | Article

HF and ejection fraction both impact CABG outcomes

Both heart failure and reduced ejection fraction influence the outcomes of patients undergoing coronary artery bypass grafting, say researchers. 

Heart failure

15-07-2016 | Heart failure | News | Article

Post-MI heart failure increases cancer risk

Myocardial infarction survivors who have heart failure are more likely to develop cancer than their heart failure-free counterparts, indicates research published in the Journal of the American College of Cardiology.